Trial Profile
Metronomic chemotherapy with cyclophosphamide and celecoxib in breast cancer patients progressing after standard chemotherapy: Phase I/II trial.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 25 Jul 2016
Price :
$35
*
At a glance
- Drugs Celecoxib (Primary) ; Cyclophosphamide (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 08 Jun 2010 Study design reported at ASCO 2010.
- 08 Jun 2010 New trial record